Name
Ascentage Pharma
Company Description
Ascentage Pharma Group is a global biopharmaceutical company engaged in developing novel therapies for various hematological disorders. The company has multiple on-going across clinical trials in all phases that involve the use of novel investigational agents such as third-generation tyrosine kinase inhibitors olverembatinib, Bcl-2 inhibitor lisaftoclax, MDM2-p53 inhibitor alrizomadlin, ALK inhibitor APG-2449, dual Bcl-2/Bcl-xL inhibitor pelcitoclax, and EED inhibitor APG-5918 to address unmet medical needs.
Website
Product Categories (5)
Gastrointestinal (Colorectal) Cancer, Lung Cancer, Melanoma/Skin Cancers, Sarcoma/Bone and Soft Tissue Cancers
Address
Rockville, MD
United States
United States